Annual Conference - Beyond One-Size-Fits-All: The Promise and Complexity of Precision Medicine
This year’s Annual Conference will explore how personalised approaches are changing the life sciences landscape, and what this means for clinical research, regulatory & medical affairs, quality, market access and, ultimately, patients.
Precision medicine is reshaping the way therapies are discovered, developed, assessed and brought to patients. From biomarker-driven treatments and radioligand therapies to adaptive clinical development, companion diagnostics, regulatory assessment and market access, innovation increasingly requires collaboration across disciplines.
PRELIMINARY PROGRAM
12:00 – 12:50
Welcome lunch & registration
12:50 – 13:00
Welcome and introduction
Setting the scene: why precision medicine requires cross-functional collaboration.
13:00 – 13:30
From Biomarkers to Better Decisions: The Clinical Promise of Precision Medicine
Jeroen De Kervel, UZ Leuven
13:30 – 14:00
Radioligand Therapies: Targeted Treatment at the Crossroads of Science, Care and Regulation
Sarah Baatout, SCK CEN
14:00 – 14:30
Designing Smarter Trials for Personalised Therapies: Adaptive Designs, Smaller Populations and Real-World Complexity
Pieter De Cock, UZ Gent
14:30 – 14:45
Healixia Award
14:45 – 15:15
Coffee break
15:15 – 15:45
Ethics Committees and Precision Medicine: Towards More Consistent Assessment in Belgium
Speaker from the Clinical Trial College / EC network
15:45 – 16:15
Joint Clinical Assessment and ATMPs: Early Lessons for Evidence, Value and Access
Speaker to be confirmed
16:15 – 16:45
Companion Diagnostics in Precision Medicine: Aligning Drug, Device and Diagnostic Pathways
Geert Martens, AZ Delta
16:45 – 17:15
Benefit–Risk Assessment in Personalised Cancer Treatments: A Regulatory Perspective
Olga Kholmanskikh, FAMHP
17:15 – 17:30
Closing reflection: the patient voice
Saartje Hendrickx, CliniClowns / patient-centred closing moment
17:30 – 19:00
Networking reception